Sermorelin Peptide – GHRH Research Peptide
Sermorelin Peptide – GHRH Research Peptide
Blog Article
Sermorelin Peptide is a synthetic 29-amino-acid analogue of growth hormone-releasing hormone (GHRH). It is designed to mimic the active N-terminal portion of natural GHRH and has been studied for Sermorelin Peptide its ability to stimulate the body's endogenous growth hormone secretion.
Sermorelin Peptide research has focused on growth hormone regulation, GH/IGF-1 signaling, endocrine function, growth-related pathways, and metabolic research. Unlike recombinant human growth hormone, Sermorelin acts upstream by stimulating the pituitary's natural release of growth hormone.
Product Highlights
29-amino-acid GHRH analogue
Researches natural growth hormone secretion
Studied in GH/IGF-1 signaling pathways
Used in endocrine and growth-hormone research
Suitable for research-focused peptide collections where permitted
Potential Research Areas of Sermorelin
Growth hormone stimulation: Research demonstrates that Sermorelin can stimulate endogenous growth hormone release through GHRH pathways.
GH/IGF-1 research: Because growth hormone influences downstream IGF-1 signaling, Sermorelin is studied within the broader GH/IGF-1 axis.
Endocrine research: Sermorelin has been investigated as a tool for studying pituitary growth-hormone secretion and endocrine function.
Growth and development research: Historical clinical research investigated Sermorelin in children with growth hormone deficiency and growth failure.
Metabolic research: The growth-hormone axis is involved in metabolism and body-composition pathways, making Sermorelin relevant to related research.
GHRH receptor research: Sermorelin provides a model for studying activation of GHRH receptors and their role in growth-hormone secretion.
Report this page